HOME >> BIOLOGY >> NEWS
Study finds shifts in treatment trends prior to publication of study results

The oral presentation of data from a single study at a national scientific conference can have an important impact on patient treatment, even before study publication or Food and Drug Administration (FDA) approval, according to a study in the March 15 issue of the Journal of the National Cancer Institute.

Specifically, the authors found that use of the chemotherapy drugs called taxanes increased after the May 1998 annual meeting of the American Society of Clinical Oncology (ASCO) where preliminary data were presented suggesting that use of taxanes as adjuvant therapy could improve survival in women with lymph node-positive breast cancer.

Results from the Cancer and Leukemia Group B (CALGB) Study 9344 suggested that adjuvant treatment with the taxane drug paclitaxel is associated with improved survival in women with lymph node-positive breast cancer. The results were first presented at the 1998 ASCO meeting. Although paclitaxel had been approved by the FDA in 1994 for the treatment of women with metastatic breast cancer, FDA approval for this new use of paclitaxel for women with node-positive breast cancer did not come until October 1999. A final report of CALGB Study 9344 was published in 2003. However, the preliminary results of the study presented in May 1998 were highlighted in news stories published in numerous major media outlets, including the New York Times, Wall Street Journal, and U.S. News and World Report.

To investigate the impact of the meeting presentation on practice patterns, Sharon H. Giordano, M.D., at the University of Texas M.D. Anderson Cancer Center, and colleagues studied chemotherapy use in 3341 women older than age 65, identified in the Surveillance, Epidemiology, and End Results-Medicare database, who were diagnosed with stage I-III breast cancer between 1994 and 1999 and received adjuvant chemotherapy within 1 year of diagnosis. The authors examined the use of taxanes among these women.
'"/>

Contact: Ariel Whitworth
jncimedia@oxfordjournals.org
301-841-1287
Journal of the National Cancer Institute
14-Mar-2006


Page: 1 2 3

Related biology news :

1. Study begins to reveal clues to the cause and progression of sepsis
2. Study finds gender differences in renal and other genes contributing to blood pressure
3. Study suggests estrogen deficiency can lead to obesity-induced high blood pressure after menopause
4. Study: Sticking to the sand might not be such good, clean fun for beachgoers
5. Study points to new way to predict death risk from torn aorta
6. Study identifies new gene therapy tools for inherited blindness
7. Study finds contaminated water reaching Floridas offshore keys
8. Study sheds light on why humans walk on two legs
9. Study explains how pathogens evolve to escape detection
10. Study finds hereditary link to premenstrual depression
11. Study identifies energy efficiency as reason for evolution of upright walking

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/23/2020)... , ... June 23, 2020 , ... ... sustainable healthcare, and Renovagen Ltd, a UK supplier and manufacturer of innovative portable ... support testing operations in the fight against the COVID-19 pandemic in Zambia. , ...
(Date:6/23/2020)... ... June 23, 2020 , ... ... pleased to announce the next event in a series of TOPIQ webinars, which ... TOPIQ series of webinars was developed in response to social distancing measures that ...
(Date:6/19/2020)... ... June 16, 2020 , ... The director of stem cell biotechnology company ... stem cell medicine and pharmaceutical industries have easier access to stem cell counting, they ... 5 of this year, Independence Day weekend in the U.S., Asymmetrex is offering free ...
Breaking Biology News(10 mins):
(Date:6/3/2020)... ... , ... Thought Technology Ltd. is offering a free webinar ... Inna Khazan will discuss the benefits of using mindfulness techniques with biofeedback. Mindfulness ... thoughts, and emotions they are having in the present moment and to respond ...
(Date:5/28/2020)... ... May 28, 2020 , ... Genedata, the leading provider of ... Screener ® 17.0, the latest version of its enterprise software for the automated ... Genedata will host a webinar on June 10, 2020, detailing and demonstrating the ...
(Date:5/21/2020)... Eden Prairie, MN (PRWEB) , ... May 19, 2020 , ... ... solution to help patients get dental implants and bone grafting through PIEZOSURGERY® ... surrounding tissues. This is often used to prepare a patient for dental implants, especially ...
(Date:5/15/2020)... ... May 14, 2020 , ... Children ... open heart surgeries before becoming adults. The reason: there are no heart ... critical unmet need, the Department of Defense has awarded Draper, Boston Children’s Hospital ...
Breaking Biology Technology:
Cached News: